Glaxosmithkline | GSK - Ebitda





Ebitda Alterar Data
AbbVie USD 3.69B 1.68B 2026-03
Amgen USD 3.86B 1.28B 2026-03
AstraZeneca USD 5.16B 510M 2026-06
Aurora Cannabis CAD 3.7M 14.78M 2026-03
Bausch Health Companies USD 1.08B 238M 2026-06
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Canopy Growth CAD -137M 134.13M 2026-03
Corcept Therapeutics USD -49M 53.2M 2026-03
Drreddys Laboratories INR 8.63B 12.96B 2026-03
Eli Lilly USD 10.29B 1.86B 2026-03
GlaxoSmithKline GBP 3.51B 734M 2026-06
Glaxosmithkline GBP 2.77B 1.98B 2026-03
J&J USD 8.27B 1.08B 2026-03
Merck USD -1.54B 7.84B 2026-03
Novartis USD 6.48B 1.19B 2026-06
Pacira USD 48.67M 8.43M 2026-06
Perrigo USD 141.6M 1.34B 2026-03
Pfizer USD 6.01B 18M 2026-06
Phibro Animal Health USD 68.1M 6.2M 2025-12
Prestige Brands USD 61.24M 23.31M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 3.69B 375M 2026-06
Supernus Pharmaceuticals USD 31.6M 2.37M 2026-06
Takeda JPY 364.46B 214.21B 2026-06
Teva Pharmaceutical Industries USD 474M 581M 2026-06
Zoetis USD 939M 0 2026-03